星空体育官方入口网站网址大全-登录入口官网

[GetPortalCommentsPageByObjectIdResponse(id=2194080, encodeId=2ef6219408091, content=偏重的研究方向：肿瘤;食管癌;胃肠 经验分享：肠胃相关都可以发，头像找我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Tue Mar 19 15:26:51 CST 2024, time=2024-03-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2186676, encodeId=001a21866e6c9, content=有一个审稿人给了一个b 一个c 没提什么实质意见，剩下的审稿人都没有回复，直接给我拒了。建议我转投另一个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884f5530521, createdName=ms2000001910337374, createdTime=Fri Feb 09 12:33:15 CST 2024, time=2024-02-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2163083, encodeId=71d2216308318, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：有没有人知道这个期刊的审稿状态啊，reviewing是什么阶段啊，求大佬告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af406151852, createdName=ms8000000868362155, createdTime=Mon Oct 16 15:24:30 CST 2023, time=2023-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140483, encodeId=e6f4214048336, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;感染 经验分享：本次2个审稿人，有个审稿人效率极其高，但是身高不认真，提了一堆问题都是原文中已经写了的。返修邮件我说明了情况，这个审稿人也没有生气，这点倒是挺好。整体来说效率很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45a88208497, createdName=ms6000000805711537, createdTime=Fri Jun 02 15:03:18 CST 2023, time=2023-06-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2111599, encodeId=3ab5211159967, content=偏重的研究方向：肿瘤;胃肠 经验分享：邀请投稿，第一个审稿人评分DC，给的大修，不知道会不会给大修的机会😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Fri Jan 27 10:22:04 CST 2023, time=2023-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1211284, encodeId=9f4512112849b, content=那个提交稿件统计学证明，大佬都在呢整得哇，求助。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=燚燚燚, createdTime=Thu Apr 14 22:34:11 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098499, encodeId=172e20984998e, content=reviewed 是在什么阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c992146749, createdName=经胸微创, createdTime=Fri Nov 04 15:25:14 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106507, encodeId=4183210650e75, content=有没有投过的老师分享一下经验呀，初审需要多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39b35703719, createdName=ms5000000599592392, createdTime=Sat Dec 17 21:00:16 CST 2022, time=2022-12-17, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=588958, encodeId=da425889587c, content=结果怎么样？审稿快吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa555318674, createdName=148a31cbm82暂无昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203712, encodeId=341b1203e12de, content=一个case而已，超级多审稿人，用的着吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Fri Mar 18 09:38:37 CST 2022, time=2022-03-18, status=1, ipAttribution=)]

2024-03-19 ms4000000361701675 来自广西

偏重的研究方向：肿瘤;食管癌;胃肠
经验分享：肠胃相关都可以发，头像找我

40 0

[GetPortalCommentsPageByObjectIdResponse(id=2194080, encodeId=2ef6219408091, content=偏重的研究方向：肿瘤;食管癌;胃肠 经验分享：肠胃相关都可以发，头像找我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Tue Mar 19 15:26:51 CST 2024, time=2024-03-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2186676, encodeId=001a21866e6c9, content=有一个审稿人给了一个b 一个c 没提什么实质意见，剩下的审稿人都没有回复，直接给我拒了。建议我转投另一个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884f5530521, createdName=ms2000001910337374, createdTime=Fri Feb 09 12:33:15 CST 2024, time=2024-02-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2163083, encodeId=71d2216308318, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：有没有人知道这个期刊的审稿状态啊，reviewing是什么阶段啊，求大佬告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af406151852, createdName=ms8000000868362155, createdTime=Mon Oct 16 15:24:30 CST 2023, time=2023-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140483, encodeId=e6f4214048336, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;感染 经验分享：本次2个审稿人，有个审稿人效率极其高，但是身高不认真，提了一堆问题都是原文中已经写了的。返修邮件我说明了情况，这个审稿人也没有生气，这点倒是挺好。整体来说效率很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45a88208497, createdName=ms6000000805711537, createdTime=Fri Jun 02 15:03:18 CST 2023, time=2023-06-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2111599, encodeId=3ab5211159967, content=偏重的研究方向：肿瘤;胃肠 经验分享：邀请投稿，第一个审稿人评分DC，给的大修，不知道会不会给大修的机会😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Fri Jan 27 10:22:04 CST 2023, time=2023-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1211284, encodeId=9f4512112849b, content=那个提交稿件统计学证明，大佬都在呢整得哇，求助。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=燚燚燚, createdTime=Thu Apr 14 22:34:11 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098499, encodeId=172e20984998e, content=reviewed 是在什么阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c992146749, createdName=经胸微创, createdTime=Fri Nov 04 15:25:14 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106507, encodeId=4183210650e75, content=有没有投过的老师分享一下经验呀，初审需要多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39b35703719, createdName=ms5000000599592392, createdTime=Sat Dec 17 21:00:16 CST 2022, time=2022-12-17, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=588958, encodeId=da425889587c, content=结果怎么样？审稿快吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa555318674, createdName=148a31cbm82暂无昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203712, encodeId=341b1203e12de, content=一个case而已，超级多审稿人，用的着吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Fri Mar 18 09:38:37 CST 2022, time=2022-03-18, status=1, ipAttribution=)]

2024-02-09 ms2000001910337374 来自北京

有一个审稿人给了一个b 一个c 没提什么实质意见，剩下的审稿人都没有回复，直接给我拒了。建议我转投另一个杂志

40 0

[GetPortalCommentsPageByObjectIdResponse(id=2194080, encodeId=2ef6219408091, content=偏重的研究方向：肿瘤;食管癌;胃肠 经验分享：肠胃相关都可以发，头像找我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Tue Mar 19 15:26:51 CST 2024, time=2024-03-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2186676, encodeId=001a21866e6c9, content=有一个审稿人给了一个b 一个c 没提什么实质意见，剩下的审稿人都没有回复，直接给我拒了。建议我转投另一个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884f5530521, createdName=ms2000001910337374, createdTime=Fri Feb 09 12:33:15 CST 2024, time=2024-02-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2163083, encodeId=71d2216308318, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：有没有人知道这个期刊的审稿状态啊，reviewing是什么阶段啊，求大佬告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af406151852, createdName=ms8000000868362155, createdTime=Mon Oct 16 15:24:30 CST 2023, time=2023-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140483, encodeId=e6f4214048336, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;感染 经验分享：本次2个审稿人，有个审稿人效率极其高，但是身高不认真，提了一堆问题都是原文中已经写了的。返修邮件我说明了情况，这个审稿人也没有生气，这点倒是挺好。整体来说效率很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45a88208497, createdName=ms6000000805711537, createdTime=Fri Jun 02 15:03:18 CST 2023, time=2023-06-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2111599, encodeId=3ab5211159967, content=偏重的研究方向：肿瘤;胃肠 经验分享：邀请投稿，第一个审稿人评分DC，给的大修，不知道会不会给大修的机会😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Fri Jan 27 10:22:04 CST 2023, time=2023-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1211284, encodeId=9f4512112849b, content=那个提交稿件统计学证明，大佬都在呢整得哇，求助。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=燚燚燚, createdTime=Thu Apr 14 22:34:11 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098499, encodeId=172e20984998e, content=reviewed 是在什么阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c992146749, createdName=经胸微创, createdTime=Fri Nov 04 15:25:14 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106507, encodeId=4183210650e75, content=有没有投过的老师分享一下经验呀，初审需要多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39b35703719, createdName=ms5000000599592392, createdTime=Sat Dec 17 21:00:16 CST 2022, time=2022-12-17, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=588958, encodeId=da425889587c, content=结果怎么样？审稿快吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa555318674, createdName=148a31cbm82暂无昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203712, encodeId=341b1203e12de, content=一个case而已，超级多审稿人，用的着吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Fri Mar 18 09:38:37 CST 2022, time=2022-03-18, status=1, ipAttribution=)]

2023-10-16 ms8000000868362155

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：食管癌
经验分享：有没有人知道这个期刊的审稿状态啊，reviewing是什么阶段啊，求大佬告知

55 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2194080, encodeId=2ef6219408091, content=偏重的研究方向：肿瘤;食管癌;胃肠 经验分享：肠胃相关都可以发，头像找我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Tue Mar 19 15:26:51 CST 2024, time=2024-03-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2186676, encodeId=001a21866e6c9, content=有一个审稿人给了一个b 一个c 没提什么实质意见，剩下的审稿人都没有回复，直接给我拒了。建议我转投另一个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884f5530521, createdName=ms2000001910337374, createdTime=Fri Feb 09 12:33:15 CST 2024, time=2024-02-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2163083, encodeId=71d2216308318, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：有没有人知道这个期刊的审稿状态啊，reviewing是什么阶段啊，求大佬告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af406151852, createdName=ms8000000868362155, createdTime=Mon Oct 16 15:24:30 CST 2023, time=2023-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140483, encodeId=e6f4214048336, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;感染 经验分享：本次2个审稿人，有个审稿人效率极其高，但是身高不认真，提了一堆问题都是原文中已经写了的。返修邮件我说明了情况，这个审稿人也没有生气，这点倒是挺好。整体来说效率很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45a88208497, createdName=ms6000000805711537, createdTime=Fri Jun 02 15:03:18 CST 2023, time=2023-06-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2111599, encodeId=3ab5211159967, content=偏重的研究方向：肿瘤;胃肠 经验分享：邀请投稿，第一个审稿人评分DC，给的大修，不知道会不会给大修的机会😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Fri Jan 27 10:22:04 CST 2023, time=2023-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1211284, encodeId=9f4512112849b, content=那个提交稿件统计学证明，大佬都在呢整得哇，求助。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=燚燚燚, createdTime=Thu Apr 14 22:34:11 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098499, encodeId=172e20984998e, content=reviewed 是在什么阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c992146749, createdName=经胸微创, createdTime=Fri Nov 04 15:25:14 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106507, encodeId=4183210650e75, content=有没有投过的老师分享一下经验呀，初审需要多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39b35703719, createdName=ms5000000599592392, createdTime=Sat Dec 17 21:00:16 CST 2022, time=2022-12-17, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=588958, encodeId=da425889587c, content=结果怎么样？审稿快吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa555318674, createdName=148a31cbm82暂无昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203712, encodeId=341b1203e12de, content=一个case而已，超级多审稿人，用的着吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Fri Mar 18 09:38:37 CST 2022, time=2022-03-18, status=1, ipAttribution=)]

2023-06-02 ms6000000805711537 来自四川省

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤;感染
经验分享：本次2个审稿人，有个审稿人效率极其高，但是身高不认真，提了一堆问题都是原文中已经写了的。返修邮件我说明了情况，这个审稿人也没有生气，这点倒是挺好。整体来说效率很快

71 0

[GetPortalCommentsPageByObjectIdResponse(id=2194080, encodeId=2ef6219408091, content=偏重的研究方向：肿瘤;食管癌;胃肠 经验分享：肠胃相关都可以发，头像找我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Tue Mar 19 15:26:51 CST 2024, time=2024-03-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2186676, encodeId=001a21866e6c9, content=有一个审稿人给了一个b 一个c 没提什么实质意见，剩下的审稿人都没有回复，直接给我拒了。建议我转投另一个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884f5530521, createdName=ms2000001910337374, createdTime=Fri Feb 09 12:33:15 CST 2024, time=2024-02-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2163083, encodeId=71d2216308318, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：有没有人知道这个期刊的审稿状态啊，reviewing是什么阶段啊，求大佬告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af406151852, createdName=ms8000000868362155, createdTime=Mon Oct 16 15:24:30 CST 2023, time=2023-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140483, encodeId=e6f4214048336, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;感染 经验分享：本次2个审稿人，有个审稿人效率极其高，但是身高不认真，提了一堆问题都是原文中已经写了的。返修邮件我说明了情况，这个审稿人也没有生气，这点倒是挺好。整体来说效率很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45a88208497, createdName=ms6000000805711537, createdTime=Fri Jun 02 15:03:18 CST 2023, time=2023-06-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2111599, encodeId=3ab5211159967, content=偏重的研究方向：肿瘤;胃肠 经验分享：邀请投稿，第一个审稿人评分DC，给的大修，不知道会不会给大修的机会😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Fri Jan 27 10:22:04 CST 2023, time=2023-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1211284, encodeId=9f4512112849b, content=那个提交稿件统计学证明，大佬都在呢整得哇，求助。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=燚燚燚, createdTime=Thu Apr 14 22:34:11 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098499, encodeId=172e20984998e, content=reviewed 是在什么阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c992146749, createdName=经胸微创, createdTime=Fri Nov 04 15:25:14 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106507, encodeId=4183210650e75, content=有没有投过的老师分享一下经验呀，初审需要多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39b35703719, createdName=ms5000000599592392, createdTime=Sat Dec 17 21:00:16 CST 2022, time=2022-12-17, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=588958, encodeId=da425889587c, content=结果怎么样？审稿快吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa555318674, createdName=148a31cbm82暂无昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203712, encodeId=341b1203e12de, content=一个case而已，超级多审稿人，用的着吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Fri Mar 18 09:38:37 CST 2022, time=2022-03-18, status=1, ipAttribution=)]

2023-01-27 少年宁来自浙江省

偏重的研究方向：肿瘤;胃肠
经验分享：邀请投稿，第一个审稿人评分DC，给的大修，不知道会不会给大修的机会😔

63 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2194080, encodeId=2ef6219408091, content=偏重的研究方向：肿瘤;食管癌;胃肠 经验分享：肠胃相关都可以发，头像找我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Tue Mar 19 15:26:51 CST 2024, time=2024-03-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2186676, encodeId=001a21866e6c9, content=有一个审稿人给了一个b 一个c 没提什么实质意见，剩下的审稿人都没有回复，直接给我拒了。建议我转投另一个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884f5530521, createdName=ms2000001910337374, createdTime=Fri Feb 09 12:33:15 CST 2024, time=2024-02-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2163083, encodeId=71d2216308318, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：有没有人知道这个期刊的审稿状态啊，reviewing是什么阶段啊，求大佬告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af406151852, createdName=ms8000000868362155, createdTime=Mon Oct 16 15:24:30 CST 2023, time=2023-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140483, encodeId=e6f4214048336, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;感染 经验分享：本次2个审稿人，有个审稿人效率极其高，但是身高不认真，提了一堆问题都是原文中已经写了的。返修邮件我说明了情况，这个审稿人也没有生气，这点倒是挺好。整体来说效率很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45a88208497, createdName=ms6000000805711537, createdTime=Fri Jun 02 15:03:18 CST 2023, time=2023-06-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2111599, encodeId=3ab5211159967, content=偏重的研究方向：肿瘤;胃肠 经验分享：邀请投稿，第一个审稿人评分DC，给的大修，不知道会不会给大修的机会😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Fri Jan 27 10:22:04 CST 2023, time=2023-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1211284, encodeId=9f4512112849b, content=那个提交稿件统计学证明，大佬都在呢整得哇，求助。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=燚燚燚, createdTime=Thu Apr 14 22:34:11 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098499, encodeId=172e20984998e, content=reviewed 是在什么阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c992146749, createdName=经胸微创, createdTime=Fri Nov 04 15:25:14 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106507, encodeId=4183210650e75, content=有没有投过的老师分享一下经验呀，初审需要多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39b35703719, createdName=ms5000000599592392, createdTime=Sat Dec 17 21:00:16 CST 2022, time=2022-12-17, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=588958, encodeId=da425889587c, content=结果怎么样？审稿快吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa555318674, createdName=148a31cbm82暂无昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203712, encodeId=341b1203e12de, content=一个case而已，超级多审稿人，用的着吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Fri Mar 18 09:38:37 CST 2022, time=2022-03-18, status=1, ipAttribution=)]

2022-04-14 燚燚燚

那个提交稿件统计学证明，大佬都在呢整得哇，求助。

82 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2194080, encodeId=2ef6219408091, content=偏重的研究方向：肿瘤;食管癌;胃肠 经验分享：肠胃相关都可以发，头像找我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Tue Mar 19 15:26:51 CST 2024, time=2024-03-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2186676, encodeId=001a21866e6c9, content=有一个审稿人给了一个b 一个c 没提什么实质意见，剩下的审稿人都没有回复，直接给我拒了。建议我转投另一个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884f5530521, createdName=ms2000001910337374, createdTime=Fri Feb 09 12:33:15 CST 2024, time=2024-02-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2163083, encodeId=71d2216308318, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：有没有人知道这个期刊的审稿状态啊，reviewing是什么阶段啊，求大佬告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af406151852, createdName=ms8000000868362155, createdTime=Mon Oct 16 15:24:30 CST 2023, time=2023-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140483, encodeId=e6f4214048336, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;感染 经验分享：本次2个审稿人，有个审稿人效率极其高，但是身高不认真，提了一堆问题都是原文中已经写了的。返修邮件我说明了情况，这个审稿人也没有生气，这点倒是挺好。整体来说效率很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45a88208497, createdName=ms6000000805711537, createdTime=Fri Jun 02 15:03:18 CST 2023, time=2023-06-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2111599, encodeId=3ab5211159967, content=偏重的研究方向：肿瘤;胃肠 经验分享：邀请投稿，第一个审稿人评分DC，给的大修，不知道会不会给大修的机会😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Fri Jan 27 10:22:04 CST 2023, time=2023-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1211284, encodeId=9f4512112849b, content=那个提交稿件统计学证明，大佬都在呢整得哇，求助。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=燚燚燚, createdTime=Thu Apr 14 22:34:11 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098499, encodeId=172e20984998e, content=reviewed 是在什么阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c992146749, createdName=经胸微创, createdTime=Fri Nov 04 15:25:14 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106507, encodeId=4183210650e75, content=有没有投过的老师分享一下经验呀，初审需要多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39b35703719, createdName=ms5000000599592392, createdTime=Sat Dec 17 21:00:16 CST 2022, time=2022-12-17, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=588958, encodeId=da425889587c, content=结果怎么样？审稿快吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa555318674, createdName=148a31cbm82暂无昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203712, encodeId=341b1203e12de, content=一个case而已，超级多审稿人，用的着吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Fri Mar 18 09:38:37 CST 2022, time=2022-03-18, status=1, ipAttribution=)]

2022-11-04 经胸微创

reviewed 是在什么阶段

74 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2194080, encodeId=2ef6219408091, content=偏重的研究方向：肿瘤;食管癌;胃肠 经验分享：肠胃相关都可以发，头像找我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Tue Mar 19 15:26:51 CST 2024, time=2024-03-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2186676, encodeId=001a21866e6c9, content=有一个审稿人给了一个b 一个c 没提什么实质意见，剩下的审稿人都没有回复，直接给我拒了。建议我转投另一个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884f5530521, createdName=ms2000001910337374, createdTime=Fri Feb 09 12:33:15 CST 2024, time=2024-02-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2163083, encodeId=71d2216308318, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：有没有人知道这个期刊的审稿状态啊，reviewing是什么阶段啊，求大佬告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af406151852, createdName=ms8000000868362155, createdTime=Mon Oct 16 15:24:30 CST 2023, time=2023-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140483, encodeId=e6f4214048336, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;感染 经验分享：本次2个审稿人，有个审稿人效率极其高，但是身高不认真，提了一堆问题都是原文中已经写了的。返修邮件我说明了情况，这个审稿人也没有生气，这点倒是挺好。整体来说效率很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45a88208497, createdName=ms6000000805711537, createdTime=Fri Jun 02 15:03:18 CST 2023, time=2023-06-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2111599, encodeId=3ab5211159967, content=偏重的研究方向：肿瘤;胃肠 经验分享：邀请投稿，第一个审稿人评分DC，给的大修，不知道会不会给大修的机会😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Fri Jan 27 10:22:04 CST 2023, time=2023-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1211284, encodeId=9f4512112849b, content=那个提交稿件统计学证明，大佬都在呢整得哇，求助。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=燚燚燚, createdTime=Thu Apr 14 22:34:11 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098499, encodeId=172e20984998e, content=reviewed 是在什么阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c992146749, createdName=经胸微创, createdTime=Fri Nov 04 15:25:14 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106507, encodeId=4183210650e75, content=有没有投过的老师分享一下经验呀，初审需要多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39b35703719, createdName=ms5000000599592392, createdTime=Sat Dec 17 21:00:16 CST 2022, time=2022-12-17, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=588958, encodeId=da425889587c, content=结果怎么样？审稿快吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa555318674, createdName=148a31cbm82暂无昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203712, encodeId=341b1203e12de, content=一个case而已，超级多审稿人，用的着吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Fri Mar 18 09:38:37 CST 2022, time=2022-03-18, status=1, ipAttribution=)]

2022-12-17 ms5000000599592392 来自甘肃省

有没有投过的老师分享一下经验呀，初审需要多久呢

60 0

[GetPortalCommentsPageByObjectIdResponse(id=2194080, encodeId=2ef6219408091, content=偏重的研究方向：肿瘤;食管癌;胃肠 经验分享：肠胃相关都可以发，头像找我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Tue Mar 19 15:26:51 CST 2024, time=2024-03-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2186676, encodeId=001a21866e6c9, content=有一个审稿人给了一个b 一个c 没提什么实质意见，剩下的审稿人都没有回复，直接给我拒了。建议我转投另一个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884f5530521, createdName=ms2000001910337374, createdTime=Fri Feb 09 12:33:15 CST 2024, time=2024-02-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2163083, encodeId=71d2216308318, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：有没有人知道这个期刊的审稿状态啊，reviewing是什么阶段啊，求大佬告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af406151852, createdName=ms8000000868362155, createdTime=Mon Oct 16 15:24:30 CST 2023, time=2023-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140483, encodeId=e6f4214048336, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;感染 经验分享：本次2个审稿人，有个审稿人效率极其高，但是身高不认真，提了一堆问题都是原文中已经写了的。返修邮件我说明了情况，这个审稿人也没有生气，这点倒是挺好。整体来说效率很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45a88208497, createdName=ms6000000805711537, createdTime=Fri Jun 02 15:03:18 CST 2023, time=2023-06-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2111599, encodeId=3ab5211159967, content=偏重的研究方向：肿瘤;胃肠 经验分享：邀请投稿，第一个审稿人评分DC，给的大修，不知道会不会给大修的机会😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Fri Jan 27 10:22:04 CST 2023, time=2023-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1211284, encodeId=9f4512112849b, content=那个提交稿件统计学证明，大佬都在呢整得哇，求助。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=燚燚燚, createdTime=Thu Apr 14 22:34:11 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098499, encodeId=172e20984998e, content=reviewed 是在什么阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c992146749, createdName=经胸微创, createdTime=Fri Nov 04 15:25:14 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106507, encodeId=4183210650e75, content=有没有投过的老师分享一下经验呀，初审需要多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39b35703719, createdName=ms5000000599592392, createdTime=Sat Dec 17 21:00:16 CST 2022, time=2022-12-17, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=588958, encodeId=da425889587c, content=结果怎么样？审稿快吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa555318674, createdName=148a31cbm82暂无昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203712, encodeId=341b1203e12de, content=一个case而已，超级多审稿人，用的着吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Fri Mar 18 09:38:37 CST 2022, time=2022-03-18, status=1, ipAttribution=)]

2020-04-15 148a31cbm82暂无昵称

结果怎么样？审稿快吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表:
投了

136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了

130 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2194080, encodeId=2ef6219408091, content=偏重的研究方向：肿瘤;食管癌;胃肠 经验分享：肠胃相关都可以发，头像找我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Tue Mar 19 15:26:51 CST 2024, time=2024-03-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2186676, encodeId=001a21866e6c9, content=有一个审稿人给了一个b 一个c 没提什么实质意见，剩下的审稿人都没有回复，直接给我拒了。建议我转投另一个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=884f5530521, createdName=ms2000001910337374, createdTime=Fri Feb 09 12:33:15 CST 2024, time=2024-02-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2163083, encodeId=71d2216308318, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：有没有人知道这个期刊的审稿状态啊，reviewing是什么阶段啊，求大佬告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af406151852, createdName=ms8000000868362155, createdTime=Mon Oct 16 15:24:30 CST 2023, time=2023-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140483, encodeId=e6f4214048336, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;感染 经验分享：本次2个审稿人，有个审稿人效率极其高，但是身高不认真，提了一堆问题都是原文中已经写了的。返修邮件我说明了情况，这个审稿人也没有生气，这点倒是挺好。整体来说效率很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45a88208497, createdName=ms6000000805711537, createdTime=Fri Jun 02 15:03:18 CST 2023, time=2023-06-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2111599, encodeId=3ab5211159967, content=偏重的研究方向：肿瘤;胃肠 经验分享：邀请投稿，第一个审稿人评分DC，给的大修，不知道会不会给大修的机会😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Fri Jan 27 10:22:04 CST 2023, time=2023-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1211284, encodeId=9f4512112849b, content=那个提交稿件统计学证明，大佬都在呢整得哇，求助。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=燚燚燚, createdTime=Thu Apr 14 22:34:11 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098499, encodeId=172e20984998e, content=reviewed 是在什么阶段, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c992146749, createdName=经胸微创, createdTime=Fri Nov 04 15:25:14 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106507, encodeId=4183210650e75, content=有没有投过的老师分享一下经验呀，初审需要多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39b35703719, createdName=ms5000000599592392, createdTime=Sat Dec 17 21:00:16 CST 2022, time=2022-12-17, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=588958, encodeId=da425889587c, content=结果怎么样？审稿快吗？136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, beContent=136bxNT2201(暂无昵称) 2019-09-21 00:00:00 发表: 投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa555318674, createdName=148a31cbm82暂无昵称, createdTime=Wed Apr 15 00:00:00 CST 2020, time=2020-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203712, encodeId=341b1203e12de, content=一个case而已，超级多审稿人，用的着吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Fri Mar 18 09:38:37 CST 2022, time=2022-03-18, status=1, ipAttribution=)]

2022-03-18 john2525

一个case而已，超级多审稿人，用的着吗？

84 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务